NCT05295459: An ongoing trial by Lyra Therapeutics
This trial is ongoing. It must report results 8 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05295459 |
|---|---|
| Title | ENLIGHTEN 2: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 13, 2022 |
| Completion date | April 2, 2025 |
| Required reporting date | April 2, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | July 17, 2025 |
| Days late | None |